Curadh MTR

Curadh MTR, Inc. is dedicated to improving and accelerating the development of molecular targeted radiotherapy for solid tumors. Curadh Clinical has an experienced team focused on the new field of Molecular Targeted Radiotherapy (MTR), with experts in all stages of oncology drug development and a proven track record of successful MTR development. It provides global, preclinical, clinical, and regulatory consulting as well as early clinical trial services to biotech and pharmaceutical companies in the MTR field seeking to transition from preclinical to early clinical development.